Our earlier study demonstrated that higher NOD1 and RIPK2 expressions were detected in the tissues of HNSCC patients than in NCMT (non-cancerous matched tissue), and identified a significant relationship between the increasing NOD1/2 expression and HNSCC progression 9. Here, RIPK2 is linked to head and neck squamous cell carcinoma.